You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

capecitabine

Showing 1 - 25 of 896
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Colorectal Cancer Stage IV Trial (Fruquintinib Plus Capecitabine, Capecitabine)

Not yet recruiting
  • Colorectal Cancer
  • Colorectal Cancer Stage IV
  • Fruquintinib Plus Capecitabine
  • Capecitabine
  • (no location specified)
Jul 9, 2022

Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)

Not yet recruiting
  • Recurrent Metastatic Nasopharyngeal Carcinoma
  • Mitoxantrone hydrochloride liposome injection
  • Capecitabine
  • (no location specified)
Jan 29, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022

Pseudomyxoma Peritonei Trial in Milano (Capecitabine)

Recruiting
  • Pseudomyxoma Peritonei
  • Capecitabine
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022

Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))

Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Capecitabine
  • PD-1 Antibody（Tislelizumab）
  • Shanghai, China
    Lulu@Huashan.Org.Cn
Aug 16, 2022

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HER2-positive Breast Cancer Trial (Margetuximab, Tucatinib, Capecitabine)

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • (no location specified)
Jul 6, 2022

Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1

Recruiting
  • Radiotherapy
  • +3 more
  • SBRT radiotherapy + Conventionally fractionated radiotherapy
  • +2 more
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-yat sen university cancer center
Jun 5, 2022

Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China

Recruiting
  • Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
  • Benowa, Queensland, Australia
  • +7 more
Jan 30, 2023

Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 22, 2022

Breast Cancer, Chemo Effect Trial (Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Capecitabine
  • (no location specified)
Mar 9, 2022

Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)

Not yet recruiting
  • Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Jun 17, 2022

Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)

Active, not recruiting
  • Elderly Metastatic Colorectal Cancer Patients
  • Capecitabine
  • +2 more
  • Padua, Italy
    Istituto Oncologico Veneto IRCCS
Mar 30, 2022

Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))

Completed
Has Results
  • Pancreatic Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Feb 10, 2022

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
Has Results
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Triple Negative Breast Cancer, Breast Cancer Trial in Stanford (Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Capecitabine
  • Stanford, California
    Stanford University
Jan 7, 2022

Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
Feb 10, 2022

Metastatic Triple-Negative Breast Cancer Trial in Beijing (Anlotinib, Capecitabine)

Recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Beijing, Beijing, China
  • +1 more
Dec 18, 2021

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022